Divide & Conquer Competitors and Similar CompaniesClear all
Divide & Conquer's competitors and similar companies include Arch Oncology.
 Divide & Conquer Divide & Conquer is focused on developing new therapeutics against glioblastoma (grade IV astrocytoma), a particularly lethal form of brain cancer, and other solid tumors with very poor life expectancy. |  Arch Oncology Arch Oncology is a clinical-stage immuno-oncology company focused on the discovery and development of antibody therapies for the treatment of patients with cancer. | |
Founding Date | Founding Date 2018 | Founding Date 2006 |
Type | Type Private | Type Private |
Tags | ||
Locations | Locations Babraham, GB HQ | Locations Brisbane, US HQ St. Louis, US |
Employees | Employees 2 | Employees 7 |
Funding | ||
Latest funding round | Latest funding round $ 12.5m (over 6 years ago) | Latest funding round $ 105m (about 5 years ago) |
Total funding raised | Total funding raised $ 12.5m | Total funding raised $ 155m |
For sources of this data, please see the company profile
View Company Profiles
Arch Oncology
HQ
Brisbane, US
Employees
7
Arch Oncology is a clinical-stage immuno-oncology company focused on the discovery and development of antibody therapies for the treatment of patients with cancer.
View company